vs
Side-by-side financial comparison of Finwise Bancorp (FINW) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $42.7M, roughly 1.8× Finwise Bancorp). Over the past eight quarters, Finwise Bancorp's revenue compounded faster (47.0% CAGR vs 31.3%).
Finwise Bancorp is a U.S.-based financial holding company that operates primarily through its community banking subsidiary. It offers a full suite of retail and commercial financial services, including deposit accounts, personal loans, mortgage products, small business financing, and wealth management solutions, serving local retail consumers and small to medium-sized business clients across its regional operating markets.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
FINW vs PBYI — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $42.7M | $75.5M |
| Net Profit | $2.7M | — |
| Gross Margin | — | 69.3% |
| Operating Margin | — | 22.7% |
| Net Margin | 6.4% | — |
| Revenue YoY | — | 27.7% |
| Net Profit YoY | — | — |
| EPS (diluted) | $0.20 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $42.7M | — | ||
| Q4 25 | $46.9M | $75.5M | ||
| Q3 25 | $36.7M | $54.5M | ||
| Q2 25 | $25.1M | $52.4M | ||
| Q1 25 | $22.1M | $46.0M | ||
| Q4 24 | $21.1M | $59.1M | ||
| Q3 24 | $20.8M | $80.5M | ||
| Q2 24 | $19.8M | $47.1M |
| Q1 26 | $2.7M | — | ||
| Q4 25 | $3.9M | — | ||
| Q3 25 | $4.9M | $8.8M | ||
| Q2 25 | $4.1M | $5.9M | ||
| Q1 25 | $3.2M | $3.0M | ||
| Q4 24 | $2.8M | — | ||
| Q3 24 | $3.5M | $20.3M | ||
| Q2 24 | $3.2M | $-4.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% |
| Q1 26 | — | — | ||
| Q4 25 | 11.7% | 22.7% | ||
| Q3 25 | 17.5% | 17.6% | ||
| Q2 25 | 21.7% | 12.7% | ||
| Q1 25 | 20.1% | 8.7% | ||
| Q4 24 | 17.5% | 22.6% | ||
| Q3 24 | 22.2% | 27.4% | ||
| Q2 24 | 21.1% | -4.6% |
| Q1 26 | 6.4% | — | ||
| Q4 25 | 8.4% | — | ||
| Q3 25 | 13.3% | 16.2% | ||
| Q2 25 | 16.3% | 11.2% | ||
| Q1 25 | 14.4% | 6.5% | ||
| Q4 24 | 13.2% | — | ||
| Q3 24 | 16.6% | 25.2% | ||
| Q2 24 | 16.1% | -9.6% |
| Q1 26 | $0.20 | — | ||
| Q4 25 | $0.27 | $0.26 | ||
| Q3 25 | $0.34 | $0.17 | ||
| Q2 25 | $0.29 | $0.12 | ||
| Q1 25 | $0.23 | $0.06 | ||
| Q4 24 | $0.19 | $0.40 | ||
| Q3 24 | $0.25 | $0.41 | ||
| Q2 24 | $0.24 | $-0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $97.5M |
| Total DebtLower is stronger | — | $22.7M |
| Stockholders' EquityBook value | $196.6M | $130.3M |
| Total Assets | $899.4M | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $163.4M | $97.5M | ||
| Q3 25 | $105.6M | $94.4M | ||
| Q2 25 | $90.1M | $96.0M | ||
| Q1 25 | $120.3M | $93.2M | ||
| Q4 24 | $109.2M | $101.0M | ||
| Q3 24 | $85.8M | $96.7M | ||
| Q2 24 | $89.0M | $96.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M |
| Q1 26 | $196.6M | — | ||
| Q4 25 | $193.2M | $130.3M | ||
| Q3 25 | $187.8M | $115.3M | ||
| Q2 25 | $182.0M | $104.7M | ||
| Q1 25 | $177.4M | $97.1M | ||
| Q4 24 | $173.7M | $92.1M | ||
| Q3 24 | $170.4M | $71.1M | ||
| Q2 24 | $165.8M | $48.5M |
| Q1 26 | $899.4M | — | ||
| Q4 25 | $977.1M | $216.3M | ||
| Q3 25 | $899.9M | $202.9M | ||
| Q2 25 | $842.5M | $194.9M | ||
| Q1 25 | $804.1M | $196.2M | ||
| Q4 24 | $746.0M | $213.3M | ||
| Q3 24 | $683.0M | $220.7M | ||
| Q2 24 | $617.8M | $205.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $14.4M |
| Free Cash FlowOCF − Capex | — | $14.4M |
| FCF MarginFCF / Revenue | — | 19.1% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-28.4M | $14.4M | ||
| Q3 25 | $3.5M | $9.7M | ||
| Q2 25 | $-18.3M | $14.1M | ||
| Q1 25 | $-21.6M | $3.6M | ||
| Q4 24 | $-15.0M | $15.6M | ||
| Q3 24 | $-9.8M | $11.0M | ||
| Q2 24 | $-7.6M | $1.0M |
| Q1 26 | — | — | ||
| Q4 25 | $-28.6M | $14.4M | ||
| Q3 25 | $3.4M | $9.7M | ||
| Q2 25 | $-19.8M | $14.1M | ||
| Q1 25 | $-23.3M | $3.6M | ||
| Q4 24 | $-16.1M | $15.6M | ||
| Q3 24 | $-13.4M | $11.0M | ||
| Q2 24 | $-7.7M | $1.0M |
| Q1 26 | — | — | ||
| Q4 25 | -61.1% | 19.1% | ||
| Q3 25 | 9.4% | 17.7% | ||
| Q2 25 | -79.0% | 26.8% | ||
| Q1 25 | -105.3% | 7.7% | ||
| Q4 24 | -76.0% | 26.4% | ||
| Q3 24 | -64.3% | 13.7% | ||
| Q2 24 | -38.7% | 2.1% |
| Q1 26 | — | — | ||
| Q4 25 | 0.5% | 0.0% | ||
| Q3 25 | 0.1% | 0.0% | ||
| Q2 25 | 5.8% | 0.0% | ||
| Q1 25 | 7.4% | 0.1% | ||
| Q4 24 | 5.1% | 0.0% | ||
| Q3 24 | 17.2% | 0.0% | ||
| Q2 24 | 0.3% | 0.0% |
| Q1 26 | — | — | ||
| Q4 25 | -7.26× | — | ||
| Q3 25 | 0.71× | 1.10× | ||
| Q2 25 | -4.48× | 2.41× | ||
| Q1 25 | -6.78× | 1.21× | ||
| Q4 24 | -5.37× | — | ||
| Q3 24 | -2.84× | 0.54× | ||
| Q2 24 | -2.39× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FINW
| Net Interest Income | $28.1M | 66% |
| Noninterest Income | $14.6M | 34% |
PBYI
Segment breakdown not available.
